Gene · 2043
Papers2,263
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,263
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Analysis of Purine-Metabolism-Related Gene Signature for Predicting Ovarian Cancer Prognosis, Immune Landscape, and Potential Treatment Options. | J Pers Med | 2023 | 37240946 | PubTator, text mining | PubMed |
| Differentially Expressed Genes Induced by Erythropoietin Receptor Overexpression in Rat Mammary Adenocarcinoma RAMA 37-28 Cells. | Int J Mol Sci | 2023 | 37239828 | PubTator, text mining | PubMed |
| Rapid Generation of Pulmonary Organoids from Induced Pluripotent Stem Cells by Co-Culturing Endodermal and Mesodermal Progenitors for Pulmonary Disease Modelling. | Biomedicines | 2023 | 37239147 | PubTator, text mining | PubMed |
| An Insight into Cellular and Molecular Mechanisms Underlying the Pathogenesis of Neurodegeneration in Alzheimer's Disease. | Biomedicines | 2023 | 37239068 | PubTator, text mining | PubMed |
| Neuropilin 1 is an entry receptor for KSHV infection of mesenchymal stem cell through TGFBR1/2-mediated macropinocytosis. | Sci Adv | 2023 | 37224259 | PubTator, text mining | PubMed |
| Activation of the HNRNPA2B1/miR-93-5p/FRMD6 axis facilitates prostate cancer progression in an m6A-dependent manner. | J Cancer | 2023 | 37215455 | PubTator, text mining | PubMed |
| Extracellular RNA in melanoma: Advances, challenges, and opportunities. | Front Cell Dev Biol | 2023 | 37215082 | PubTator, text mining | PubMed |
| 3D genome perspective on cell fate determination, organ regeneration, and diseases. | Cell Prolif | 2023 | 37199020 | PubTator, text mining | PubMed |
| Author Correction: Increased EphA4-ephexin1 signaling in the medial prefrontal cortex plays a role in depression-like phenotype. | Sci Rep | 2023 | 37198278 | PubTator, text mining | PubMed |
| Multiomics analysis of adaptation to repeated DNA damage in prostate cancer cells. | Epigenetics | 2023 | 37196186 | PubTator, text mining | PubMed |
| Insight on the hub gene associated signatures and potential therapeutic agents in epilepsy and glioma. | Brain Res Bull | 2023 | 37192718 | PubTator, text mining | PubMed |
| Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases. | Cell Commun Signal | 2023 | 37189112 | PubTator, text mining | PubMed |
| Isthmin-1 (Ism1) modulates renal branching morphogenesis and mesenchyme condensation during early kidney development. | Nat Commun | 2023 | 37185772 | PubTator, text mining | PubMed |
| Angiogenic signaling pathways and anti-angiogenic therapy for cancer. | Signal Transduct Target Ther | 2023 | 37169756 | PubTator, text mining | PubMed |
| Targeting EFNA1 suppresses tumor progression via the cMYC-modulated cell cycle and autophagy in esophageal squamous cell carcinoma. | Discov Oncol | 2023 | 37160815 | PubTator, text mining | PubMed |
| α-cell electrophysiology and the regulation of glucagon secretion. | J Endocrinol | 2023 | 37159865 | PubTator, text mining | PubMed |
| Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival. | Proc Natl Acad Sci U S A | 2023 | 37155874 | PubTator, text mining | PubMed |
| Genomic Diversity of Methicillin-Resistant Staphylococcus aureus CC398 Isolates Collected from Diseased Swine in the German National Resistance Monitoring Program GERM-Vet from 2007 to 2019. | Microbiol Spectr | 2023 | 37154741 | PubTator, text mining | PubMed |
| EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells. | PLoS Pathog | 2023 | 37146061 | PubTator, text mining | PubMed |
| Gene Set Based Integrated Methylome and Transcriptome Analysis Reveals Potential Molecular Mechanisms Linking Cigarette Smoking and Related Diseases. | OMICS | 2023 | 37145884 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2043/papers?page=10